Morningstar Investor users sign in here.

Company Profile

  • Business description

    As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

  • Contact

    Avinguda de la Generalitat, 152
    Parc de Negocis Can Sant Joan
    Sant Cugat del Valles
    Barcelona 08174
    ESP

    T: +34 935712200

    E: investors@grifols.com

    https://www.grifols.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    23,737

Grifols SA News & Analysis

stocks

6 undervalued stocks with low beta

Berkshire Hathaway and Verizon are among the low-volatility stocks that trade at a discount.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,243.30 19.10 -0.23%
CAC 40 7,571.41 61.30 -0.80%
DAX 40 18,484.32 106.57 -0.57%
Dow JONES (US) 40,211.72 210.82 0.53%
FTSE 100 8,141.91 41.05 -0.50%
HKSE 17,727.98 287.96 -1.60%
NASDAQ 18,472.57 74.12 0.40%
Nikkei 225 41,275.08 84.40 0.20%
NZX 50 Index 12,184.49 61.35 0.51%
S&P 500 5,631.22 15.87 0.28%
S&P/ASX 200 7,999.30 18.30 -0.23%
SSE Composite Index 2,976.30 2.29 0.08%

Market Movers

Name
Last price
Change
% Change
Droneshield Ltd DRO 2.02 0.58 -22.31%
Sayona Mining Ltd SYA 0.03 0.00 -2.94%
Red 5 Ltd RED 0.42 0.00 0.00%
Mirvac Group MGR 2.12 0.04 1.92%
Opthea Ltd OPT 0.38 0.01 -1.32%
Imugene Ltd IMU 0.06 0.00 -3.51%
Telstra Group Ltd TLS 3.83 0.01 -0.26%
Bellevue Gold Ltd BGL 1.87 0.07 -3.37%
Latin Resources Ltd LRS 0.16 0.01 -5.88%
Zip Co Ltd ZIP 1.61 0.03 1.90%